Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

INTRODUCTION: Antibodies against mutated citrullinated vimentin (AMCV) represent a useful diagnostic marker with correlation to disease activity in patients with rheumatoid arthritis (RA). Since seropositivity for citrullinated autoantibodies was predictive for response to B-cell depleting therapy (...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arthritis Res Ther
Hlavní autoři: Lindenberg, Luisa, Spengler, Lydia, Bang, Holger, Dorner, Thomas, Maslyanskiy, Aleksej L, Lapin, Sergey V, Ilivanova, Elena I, Martinez-Gamboa, Lorena, Bastian, Hans, Wittenborn, Esther, Egerer, Karl, Burmester, Gerd-R, Feist, Eugen
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535682/
https://ncbi.nlm.nih.gov/pubmed/26268352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-015-0717-z
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky